Oncotelic Therapeutics, Inc.
OTLC· OTC
OTLCOncotelic Therapeutics, Inc.
Filed May 14, 2020 · 10-K · 135 days after period end · 0001493152-20-008845
derived · Computed from the longer spans the company filed.
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$3.48M | -$154.60K | -$2.43M | -$3.45M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oncotelic Therapeutics, Inc. · CIK 908259 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed May 14, 2020 · 135 d after period end
